The content is available as a PDF (219.3 KB).
Footnotes
The “Journal of Cancer Research and Clinical Oncology” publishes in loose succession “Editorials” and “Guest editorials” on current and/or controversial problems in experimental and clinical oncology. These contributions represent exclusively the personal opinion of the authors. The Editors
References
- Brennan MF, Kinsella TJ, Casper ES (1993) Cancer of the pancreas. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer, principles and practice of oncology, 4th edn. Lippincott, Philadelphia, pp 849–882 [Google Scholar]
- Cellerino R, Tummarello D, Guidi F, Isidori P, Raspugli, Biscottini B, Fatati G (1991) A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small-cell lung cancer J Clin Oncol 9:1453–1461 [DOI] [PubMed] [Google Scholar]
- Eddy DM (1992) High-dose chemotherapy with autologous bone marrow transplantation for the treatment of metastatic breast cancer. J Clin Oncol 10:657–670 [DOI] [PubMed] [Google Scholar]
- Ganz PA, Figlin RA, Haskell CM, La Soto N, Siau J (1989) Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference? Cancer 63:1271–1278 [DOI] [PubMed] [Google Scholar]
- Kennedy MJ, Beveridge RA, Rowley SD, Gordon GB, Abeloff MD, Davidson NE (1991) High-dose chemotherapy with reinfusion of purged autologous, bone marrow following dose-intense induction as initial therapy for metastatic breast cancer. J Natl Cancer Inst 83:920–926 [DOI] [PubMed] [Google Scholar]
- Markman M (1988) An argument in support of cost-effectiveness analysis in oncology. J Clin Oncol 6:937–939 [DOI] [PubMed] [Google Scholar]
- Rapp E, Pater JL, Willan A, Cormier Y, Murray N Evans WK, Hodson DI, Clark DA, Feld R, Arnold AM, Ayoub JI, Wilson KS, Latreille J, Wierzbicki RF, Hill DP (1988) Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer-report of a Canadian multicenter randomized trial. J Clin Oncol 6:633–641 [DOI] [PubMed] [Google Scholar]
- Rorth M (1992) Therapeutic alternatives in clinical stage I nonseminomatous disease. Semin Oncol 19:190–196 [PubMed] [Google Scholar]
- Rosenberg SA, Yang JC, Topalian SL, Schwartzentruber DJ, Weber JS, Parkinson DR, Seipp CA, Einhorn JH, White DE (1994), Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2. JAMA 271:907–913 [PubMed] [Google Scholar]
- Williams SF, Gilewski T, Mick R, Bitran JD (1992) High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: follow-up report. J Clin Oncol 10:1743–1747 [DOI] [PubMed] [Google Scholar]